Experimental Dry Eye Treatment NEt-3IB Shows Promise by Enhancing Immune Cell Protection in Mouse Study
By
StudyFinds Analysis
Baker's choice. Dense with flavour, light on filler.
Summary
Researchers at Baylor College of Medicine have developed an experimental treatment for dry eye disease called NEt-3IB that works by training the eye's immune cells (neutrophils) to better protect themselves, rather than simply suppressing inflammation like current treatments. In mouse studies, the treatment reduced corneal damage by 80% and improved tear production by 70% compared to untreated eyes. Unlike corticosteroids which can increase eye pressure with long-term use, NEt-3IB targets the root cause by helping immune cells form protective neutrophil extracellular traps (NETs) more effectively, offering a potentially safer approach to managing dry eye disease.
Key quotes
· 3 pulled'We're not just suppressing the immune system — we're giving it the tools it needs to protect the eye more effectively,' said Dr. Cintia S. de Paiva, professor of ophthalmology at Baylor College of Medicine and senior author of the study.
'This is a fundamentally different way of thinking about treating dry eye,' said Dr. de Paiva. 'Instead of just managing symptoms, we're addressing the underlying problem at the cellular level.'
'The results were striking. We saw an 80% reduction in corneal damage and a 70% improvement in tear production in treated mice compared to untreated controls,' said Dr. de Paiva.
You might also wanna read
Eye Drops Show Promise as Alternative to Glasses and Surgery for Presbyopia
Researchers have developed special eye drops that could replace reading glasses or surgery for people with presbyopia (longsightedness). The
theguardian.com·8mo ago
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
npr.org·15h ago
GeneSkin Develops mRNA Therapy Targeting Skin Stem Cells for Rejuvenation and Hair Growth
GeneSkin is developing a novel mRNA therapy targeting basal stem cells in the skin to address a wide range of dermatological issues includin
wyss.harvard.edu·17h ago
First human trial begins for drug that could regrow missing teeth
Kyoto University Hospital has launched the first human trial of TRG-035, a drug designed to regrow teeth in adults by blocking a protein tha
boingboing.net·1d ago
Japanese researchers develop vitamin K-like compounds that may help convert brain cells into neurons
Japanese researchers have developed a new family of vitamin K-like molecules that may help immature brain cells transition into neurons. Whi
zmescience.com·1d ago
International trial shows DNA test could help many breast cancer patients avoid chemotherapy
A new international trial presented at the American Society of Clinical Oncology conference suggests that millions of breast cancer patients
bbc.co.uk·1d ago